Skip to content

Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy

Ultrasoundguided Transmuscular Quadratus Lumborum Block After Elective Laparoscopic Cholecystectomy. A Prospective, Randomized Clinical Trial.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02225418
Acronym
TQL
Enrollment
0
Registered
2014-08-26
Start date
2014-11-30
Completion date
Unknown
Last updated
2015-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis, Pain

Keywords

Laparoscopic, Cholecystectomy, Postoperative, Pain, Quadratus lumborum, Ultrasound

Brief summary

The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder. The trial will compare active TQL block versus placebo TQL block after said operation. The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.

Interventions

DRUGRopivacaine
DRUGsaline

Sponsors

Bispebjerg Hospital
CollaboratorOTHER
Jens Borglum Neimann
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* scheduled for elective laparoscopic cholecystectomy * received oral and written information about the trial * American Society of Anaethesiologists (ASA) classification 1-3 * NRS score \> 3 upon arrival at the PACU area

Exclusion criteria

* Cannot cooperate * Does not speak or understand Danish * Allergy towards drugs used in the trial * Large daily consumption of opioids * Known alcohol og medicin abuse * Difficult or impossible by ultrasound to visualise the intended nerve/tissue structures necessary to perform block * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Pain score in sitting position1 hourNumerical Rating Scale (NRS) score 1 hour after administration of TQL block

Secondary

MeasureTime frameDescription
Pain score at rest15 min, 30 min, 1 hour 2 hour 3 hour 4 hour 5 hourNRS score after administration of TQL block at said time points
Pain score at sitting position15 min 30 min 2 hour 3 hour 4 hour 5 hourNRS score after administration of TQL block at said time points
Total opioid consumption in PACU areaOn average 3 hoursDuring stay in PACU area
Opioid side effects (nausea, vomiting)On average 3 hoursDuring stay in PACU area
Length of stay in PACU areaOn average 3 hoursTotal time in PACU area

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026